2-OXO-8-AZA-SPIRO[4.5]DECANE-8-CARBOXYLIC ACID TERT-BUTYL ESTER, 95.0%, 10g

(R)-N-(Piperidin-3-yl)nicotinamide dihydrochloride, 95.0%, 1g

3-(3-Methyl-3H-diazirin-3-yl)-N-((2S,3R,4S,5R)-3,4,5,6-tetrahydroxy-1-oxohexan-2-yl)propanamide, 97%, 100mg

trans-beta-Farnesene>95.0%(GC)1g

1-[2-(isopropylamino)-4-methyl-1,3-thiazol-5-yl]ethanone, 5g

3-Methyloxetane-3-carboxylic acid, 98.0%, 250mg

2,4-DICHLORO-7H-PYRROLO[2,3-D]PYRIMIDINE-7-CARBOXYLIC ACID 1,1-DIMETHYLETHYL ESTER, 95.0%, 1g

2-Chloro-4-dimethylamino-benzoic acid, 5g

Copper(II) acetate monohydrate, min. 99%, pa, ACS, 50 g, plastic packaging.

Ethyl 1-aminocyclopentanecarboxylate hydrochloride, 95.0%, 5g

Potassium tetrakis(1-pyrazolyl)borate, 98%, 5g

3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-fluorophenyl)propanoic acid, 97%, 250mg

3-(2-Chloro-6-fluorophenyl)-5-methylisoxazole-4-carbonitrile, 95.0%, 1g